How to Improve Access to Malaria Treatment in the Private Sector

PSI recently hosted a webinar on how to transform the market for malaria rapid diagnostic tests (mRDTs) in the private sector. Panelists from PSI and four partner organizations, including the World Health Organization (WHO), Foundation for Innovative New Diagnostics (FIND), Johns Hopkins Bloomberg School of Public Health, and Malaria Consortium, dove deep into the lessons

Read More
malaria

PSI Contributes New Chapter to Springer’s “Encyclopedia of Malaria”

PSI recently published a chapter in Springer Publishing’s “Encyclopedia of Malaria.” “Malaria Diagnostics in the Private Sector” provides the most up-to-date findings and recommendations related to malaria diagnosis in the private health sector. Drawn largely from PSI’s experience implementing the UNITAID funded private sector malaria rapid diagnostics tests (mRDTs) project, the chapter focuses on the

Read More

7 Questions for UNITAID Director Lelio Marmora

By Sandy Garcon, Communications Manager, PSI  UNITAID’s executive director discusses the importance of developing and unlocking markets to accelerate innovations in growth.  1. Impact: Why are markets systems important to the poor? LM: The poorest people are typically the most vulnerable in society, and often the most directly affected by changing or underdeveloped market conditions

Read More
End TB

Why TB Isn’t Yet Out of Breath

By Karl Hofmann, PSI President and CEO Despite over a century of remarkable progress, tuberculosis remains the world’s deadliest, yet preventable and treatable disease. While our attention focused on the more headline-grabbing malaria and Ebola, TB quietly rose as top infectious killer on the planet. Every year, around 9.6 million people worldwide are infected with

Read More

PSI and UNITAID Launch First Effort Ever to Catalyze HIV Self-Testing in Africa

In celebration of World AIDS Day, Population Services International (PSI) and UNITAID launch the first phase of a four-year project that will scale up HIV self-testing in Malawi, Zambia and Zimbabwe.

Washington, DC; Harare, Zimbabwe – November 30th, 2015 – Today, on the eve of World AIDS Day, PSI joined UNITAID, the World Health Organization and ministry of health officials from Malawi, Zambia and Zimbabwe to launch the UNITAID/PSI HIV Self-Testing Africa (STAR) Project at the 18th International Conference on AIDS and STIs in Africa (ICASA).

Read More

UNITAID and PSI Partner to Expand Access to HIV Self-Testing

Globally, there are an estimated 19 million people who do not know they are living with HIV. Without knowledge of their status, individuals cannot access life-saving HIV care and treatment. To close this gap, UNITAID is investing $23 million to accelerate access to HIV testing through simple HIV self-tests in three high-burden African countries over

Read More

Innovative Finance and its Promise for Global Health

      Few global health institutions focus as much on innovative finance as UNITAID. The global health initiative, established in 2006 and hosted by the World Health Organization in Geneva, uses its understanding of how to address market shortcomings to improve access to quality-assured treatment and diagnostics for HIV and AIDS, tuberculosis and malaria patients in low-income

Read More

A New Chapter in Tuberculosis Diagnostics

By Petra Stankard, HIV/TB Technical Advisor at PSI

In 1882, Robert Koch discovered the bacteria that caused tuberculosis (TB) and introduced sputum smear microscopy as a method for diagnosing the disease. It was a major scientific advancement. Thousands of scientific advances have followed—we’ve walked on the moon, eradicated smallpox and discovered the makeup of an atom. But until recently, in laboratories throughout the developing world, the diagnosis of tuberculosis remained firmly rooted in Koch’s discovery.

Unfortunately, smear microscopy is far from a flawless diagnostic tool. Time-consuming and cumbersome, smear microscopy often fails to detect TB in people living with HIV (one of the populations most at risk for TB disease) limiting efforts to prevent unnecessary deaths. Added to that, microscopy cannot identify whether the TB bacilli present in a smear are drug resistant. This consequently slows diagnosis and treatment of multi-drug resistant TB even as it becomes a growing health problem.

Read More

Social Marketing for Safe Drinking Water in Cameroon

Ed note. This post is by Mark Leon Goldberg, PSI Healthy Lives editor. I visited Cameroon last week as part of a delegation accompanying UNITAID Chair Philippe Douste-Blazy, who is also a UN undersecretary general and the former French foreign minister. UNITAID is a World Health Organization-affiliated organization that seeks to raise funds for global

Read More

Healthy Dose August 26, 2011

Top Story Bacteria-Injected Mosquitoes Blocked From Spreading Dengue Fever A team of Australian researchers have discovered a breakthrough in the reduction of dengue. By injecting mosquitoes with a bacteria, they were able to block them from transmitting the virus that kills 20,000 people a year. The Guardian reports: In two papers published in the journal

Read More

Healthy Dose July 13, 2011

Top Story UNITAID Patent Pool Kicks Off The Medicines Patent Pool, established by UNITAID to share drug patents, has just received its first contribution from Gilead Sciences. Sarah Boseley writes in Guardian Development why this is such a big deal. Gilead is the first pharma company to agree to put specific drug patents in the

Read More

Bill Clinton, DFID and UNITAID Negotiate Huge Price Cuts for AIDS Drugs

HIV/AIDS patients in the developing world just got handed a potential lifeline in the form of sharply reduced drug costs. A partnership between Bill Clinton’s Clinton Health Access Initiative, UNITAID and The UK’s Department for International Development was able to secure significant price reductions for first and second line HIV medicines. This means that health

Read More